Pseudolaric acid B
Names
[ CAS No. ]:
82508-31-4
[ Name ]:
Pseudolaric acid B
[Synonym ]:
(2E,4E)-5-[(1R,7S,8R,9R)-4,7-Bis(methoxycarbonyl)-9-methyl-11-oxo-10-oxatricyclo[6.3.2.0]tridec-3-en-9-yl]-2-methylpenta-2,4-dienoic acid
(2E,4E)-5-[(1S,7S,8S,9R)-7-Acetoxy-4-(methoxycarbonyl)-9-methyl-11-oxo-10-oxatricyclo[6.3.2.0]tridec-3-en-9-yl]-2-methyl-2,4-pentadienoic acid
1H-4,9a-Ethanocyclohepta[c]pyran-7-carboxylic acid, 4a-(acetyloxy)-3-[(1E,3E)-4-carboxy-1,3-pentadien-1-yl]-3,4,4a,5,6,9-hexahydro-3-methyl-1-oxo-, 7-methyl ester, (3R,4S,4aS,9aS)-
(2E,4E)-5-[(1R,7S,8R,9R)-4,7-Bis(methoxycarbonyl)-9-methyl-11-oxo-10-oxatricyclo[6.3.2.0]tridec-3-en-9-yl]-2-methyl-2,4-pentadienoic acid
1H-4,9a-Ethanocyclohepta[c]pyran-4a,7(5H)-dicarboxylic acid, 3-[(1E,3E)-4-carboxy-1,3-pentadien-1-yl]-3,4,6,9-tetrahydro-3-methyl-1-oxo-, 4a,7-dimethyl ester, (3R,4R,4aS,9aR)-
PLAB
(2E,4E)-5-[(1S,7S,8S,9R)-7-Acetoxy-4-(methoxycarbonyl)-9-methyl-11-oxo-10-oxatricyclo[6.3.2.0]tridec-3-en-9-yl]-2-methylpenta-2,4-dienoic acid
PseudolaricAcidB
Pseudolarix acid B
Biological Activity
[Description]:
[Related Catalog]:
[References]
Chemical & Physical Properties
[ Density]:
1.3±0.1 g/cm3
[ Boiling Point ]:
613.8±55.0 °C at 760 mmHg
[ Melting Point ]:
166°C
[ Molecular Formula ]:
C23H28O8
[ Molecular Weight ]:
432.464
[ Flash Point ]:
208.8±25.0 °C
[ Exact Mass ]:
432.178406
[ PSA ]:
116.20000
[ LogP ]:
2.78
[ Appearance of Characters ]:
white to off-white
[ Vapour Pressure ]:
0.0±3.8 mmHg at 25°C
[ Index of Refraction ]:
1.565
[ Storage condition ]:
2-8°C
[ Water Solubility ]:
methanol: soluble1mg/mL, clear, colorless
MSDS
Safety Information
[ Symbol ]:
GHS06, GHS08
[ Signal Word ]:
Danger
[ Hazard Statements ]:
H301-H361
[ Precautionary Statements ]:
P281-P301 + P310
[ Hazard Codes ]:
T
[ Risk Phrases ]:
25-62
[ Safety Phrases ]:
36/37-45-24/25
[ RIDADR ]:
UN 2811 6.1 / PGIII
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Articles
Acta Pharmacol. Sin. 33(9) , 1103-11, (2012)
In the past decade, the success of angiogenesis inhibitors in clinical contexts has established the antiangiogenic strategy as an important part of cancer therapy. During that time period, we have dis...
Bcl-2 family proteins were involved in pseudolaric acid B-induced autophagy in murine fibrosarcoma L929 cells.J. Pharmacol. Sci. 107(3) , 295-302, (2008)
Pseudolaric acid B (PAB) exerted cytostatic activity on murine fibrosarcoma L929 cells. The cytostatic mechanism of PAB on L929 cells was investigated in this paper. At 36 h, after 80 microM PAB treat...
In vitro synergy of pseudolaric acid B and fluconazole against clinical isolates of Candida albicans.Mycoses 54(5) , e400-6, (2011)
Candida albicans is the most common fungal pathogen in humans. The emergence of resistance to azole antifungals has raised the issue of using such antifungals in combination to optimise therapeutic ou...